Overview
Maja Niksic practices practicing medicine in Canterbury, United Kingdom.
Her clinical expertise encompasses Pancreatic Cancer, Anal Cancer, Pancreatic Islet Cell Tumor, and Obesity.
She is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Maja Niksic
Is Maja Niksic a top-rated expert for Pancreatic Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Maja Niksic is classified as an Experienced expert for Pancreatic Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Maja Niksic participate in research or clinical trials?
Yes. Maja Niksic has published 11 articles and abstracts on conditions like Pancreatic Cancer. You can view a list of Maja Niksic's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Anal CancerMs. Niksic isExperienced. Learn about Anal Cancer.
- ObesityMs. Niksic isExperienced. Learn about Obesity.
- Pancreatic CancerMs. Niksic isExperienced. Learn about Pancreatic Cancer.
- Pancreatic Islet Cell TumorMs. Niksic isExperienced. Learn about Pancreatic Islet Cell Tumor.